Login

Eli Lilly To Boost Size of North Carolina Plant To Meet Increased Demand for Diabetes Drug

Pharmaceutical Giant Expands Investment to $920 Million for North Carolina Drug Manufacturing Facility

Photo of the new manufacturing plant in North Carolina that Eli Lilly & Co. plans to expand through an additional $450 million investment. (Eli Lilly & Co.)
Photo of the new manufacturing plant in North Carolina that Eli Lilly & Co. plans to expand through an additional $450 million investment. (Eli Lilly & Co.)

Global pharmaceutical company Eli Lilly & Co. announced plans to enlarge the scope of its manufacturing plant under construction in the Raleigh-Durham, North Carolina, area because of the rising popularity of its diabetes drugs.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In